Claravis - Newsfeeds

Triglycerides: The forgotten fat
medications such as high-dose thiazide diuretics or beta blockers, estrogen, tamoxifen, steroids, isotretinoin, and some anti-HIV drugs. Inheritance also plays a role. Some people have high triglycerides due to genetic disorders, such as familial combined ...
FDA Setbacks Make Vivus a Buying Opportunity
Of course there are after-market measures to reduce the risks of birth while on QNEXA. For example, the SMART and iPLEDGE program with isotretinoin, or Accutane, were FDA approved mitigation strategies. The iPLEDGE program is a mandatory distribution ...
Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA
Most people would never suspect that a "trash tree," one with little economic value and often removed by farmers due to its ability to destroy farmland, could be the key to fighting a deadly bacterium. Now, a University of Missouri researcher has found an ...
Notice of Cipher Pharmaceuticals inc. Fiscal 2010 Fourth Quarter and Year End Conference Call
Cipher's second product, an extended-release version of the pain reliever tramadol, received FDA approval in May 2010 and the Company's third product, a novel formulation of the acne treatment isotretinoin, is in its final Phase III safety study.
Patient Violence Against Health Care Professionals
According to police, Peterson saw Dr Cornbleet for only 1 visit in April 2002. Isotretinoin (Accutane) was prescribed for acne. Dr Cornbleet had been in private practice in Chicago for 30 years. He had a high-volume caseload and saw more than 100 patients a week.
Cipher turns around Q4 loss into $100,000 profit
During the quarter, Cipher completed patient enrolment in a double-blind safety trial for CIP-Isotretinoin which compares it to an FDA-approved, commercially available drug. The company expects the trial to end by the second quarter this year and expects ...
CIPHER REPORTS FISCAL 2010 FINANCIAL RESULTS
"The year was also highlighted by important product milestones, including final FDA approval on our extended-release tramadol and excellent progress with our pivotal Phase III safety study for CIP-ISOTRETINOIN - the largest, most comprehensive trial ...
Central Brazil (Alta Floresta, Pantanal, Emas NP) - August 2008
After several short trips to Central America and northern South America, we finally had enough vacation time saved up to make the pilgrimage to that vast mecca of neotropical birding, Brazil. Nonetheless, we could still only afford three weeks, so decided ...
Southern Ecuador
Having visited Northern Ecuador and the Amazon the previous year and seen pictures of Jocotoco Antpitta, I decided to plan a trip to Southern Ecuador, with the prime objective of trying to see this species whilst also attempting to see as many of the other ...
The Best Make-Up Products for Acne
I suffered with bad acne for a little over 6 years before I found a dermatologist who prescribed me with Claravis (a generic form of Accutane). I'm not talking about a few pimples here or there, or a break out twice a month; I'm talking about real acne ...
Severe acne may up suicide risk: study
Isotretinoin, which has been used to treat severe acne since the 1980s, is also sold under the brand names Roaccutane, Amnesteem, Claravis, Clarus and Decutan. Accutane has been linked to birth defects, and in 2005 the U.S. Food and Drug Administration ...
Santarus And Pharming Announce Receipt Of FDA Refusal To File Letter For RHUCIN Biologics License Application
Specialty biopharmaceutical company Santarus, Inc. (NASDAQ:SNTS) and biotech company Pharming Group NV (NYSE Euronext:PHARM) announced the receipt of a "refusal to file" letter from the U.S. Food and Drug Administration (FDA) for the RHUCIN® (recombinant ...
Tanning Bed Exposure Can Be Deadly When Complicated By Medication Reactions
Tanning bed exposure can produce more than some tanners may bargain for, especially when they self-diagnose and use the radiation to treat skin eruptions, according to research conducted by the Indiana University School of Medicine Department of ...
Suicidal Teens: Pimples, Not Prescription Acne Treatments, Might Be to Blame
and that has made many dermatologists cautious about prescribing isotretinoin," Halvorsen told Reuters . "Our study is important because it provides an argument for not being so cautious." Of course, this study isn't the final word on a potential ...
Cipher Receives Notice of Allowance From US Patent office for Cip-Tramadol ER
Cipher is developing formulations of the pain reliever tramadol (FDA approval in May 2010) and the acne treatment isotretinoin (FDA approvable letter in April 2007). Statements made in this news release, other than those concerning historical financial ...
Acne Drug Found Less Harmful if Used in Lower Dose Regimens
It has been concluded after a review of more than 1700 New3 Zealand patients, that the acne drug, isotretinoin, which was initially originally sold as Accutane and Roaccutane, results in comparatively lesser side effects ...
Isotretinoin safer in low doses
The acne drug isotretinoin appears to cause few adverse reactions when used in lower dose regimens, a review of more than 1700 patients suggests. When used in doses of around 10–20 mg per day for patients with acne ...
Don’t minimize the effects of acne on teens
Accutane, or isotretinoin, will be considered for severe, resistant and difficult cases which have not improved satisfactorily during other treatments. Accutane is the only drug that “shuts off” and shrinks oil ...
Acne Blue Light
More severe cases can be effectively treated with an oral drug called isotretinoin (a synthetic form of vitamin A). Most patients who take this drug have complete or near-complete resolution of acne after taking it for ...
Side Effects of Accutane May be Reduced with Lower Doses: Study
Accutane (isotretinoin) has been used by more than 16 million people worldwide since it was first introduced in the early 1980s as a treatment for severe acne. Roche discontinued the drug in June 2009, citing cost of ...
Want to contact a Claravis lawyer in District of Columbia? ...Get a free case evaluation from one of our Claravis lawyers in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.


Pages:   1   2   Next

Need A Claravis Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Claravis lawyer in District of Columbia? ...Get a free case evaluation from one of our Claravis lawyers in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Claravis Case - Submit Your Information Below

Do you need legal assistance with your Claravis case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Claravis Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.